Publication Results (69)

• «
• 1
• 2
• »

• Time to adjuvant chemotherapy and survival in non-small cell lung cancer: a population-based study

  Booth CM, Shepherd FA, Peng Y, Darling G, Li G, Kong W, Biagi JJ, Mackillop WJ. Cancer. 2013; 119(6):1243-50. Epub 2012 Nov 6.

• Overview of lung cancer surgery in Ontario

  Bendzsak A, Nenshi R, Darling G, Schultz SE, Gunraj N, Wilton AS, Simunovic M, Jacob B, Urbach DR. Ann Thorac Surg. 2011; 91(2):361-6.

• Lung cancer inequalities in stage of diagnosis in Ontario, Canada

  Lofters AK, Gatov E, Lu H, Baxter NN, Guilcher SJT, Kopp A, Vahabi M, Datta GD. Curr Oncol. 2021; 28(3):1946-56. Epub 2021 May 23. DOI: https://doi.org/10.3390/curroncol28030181

• End-of-life care in lung cancer patients in Ontario: aggressiveness of care in the population and a description of hospital admissions

  Barbera L, Paszat L, Qiu F. J Pain Sympton Manage. 2008; 35(3):267-74. Epub 2008 Jan 14.

• Regionalization and outcomes of lung cancer surgery in Ontario, Canada

  Bendzsak AM, Baxter NN, Darling GE, Austin PC, Urbach DR. J Clin Oncol. 2017; 35(24):2772-80. Epub 2017 Jul 6.

• Venous thromboembolism in surgical lung cancer patients: a provincial population-based study

  Akhtar-Danesh G, Akhtar-Danesh N, Shargall Y. Ann Thorac Surg. 2021; Nov 13 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.athoracsur.2021.10.018

• Severe symptoms persist for up to one year after diagnosis of stage I-III lung cancer: an analysis of province-wide patient reported outcomes

  Hirpara DH, Gupta V, Davis LE, Zhao H, Hallet J, Mahar AL, Sutradhar R, Doherty M, Louie AV, Kidane B, Darling G, Coburn NG. Lung Cancer. 2020; 142:80-9. Epub 2020 Feb 25. DOI: https://doi.org/10.1016/j.lungcan.2020.02.014

• Trends in survival based on treatment modality in non-small cell lung cancer patients: a population-based study

  Akhtar-Danesh N, Akhtar-Danesh GG, Seow HY, Shakeel S, Finley C. Cancer Invest. 2019; 37(8):355-66. Epub 2019 Aug 22. DOI: 10.1080/07357907.2019.1653465.

• Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer

  Lathan CS, Neville BA, Earle CC. J Clin Oncol. 2008; 26(26):4347-52.

• Uptake and survival effects of minimally invasive surgery for lung cancer: a population-based study

  Akhtar-Danesh GG, Akhtar-Danesh N, Finley C. Eur J Surg Oncol. 2021; 47(7):1791-6. Epub 2021 Jan 12. DOI: https://doi.org/10.1016/j.ejso.2021.01.002

• Operationalizing outpatient palliative care referral criteria in lung cancer patients: a population-based cohort study using health administrative data

  Iqbal J, Sutradhar R, Zhao H, Howell D, O'Brien MA, Seow H, Dudgeon D, Atzema C, Earle CC, DeAngelis C, Sussman J, Barbera L. J Palliat Med. 2020; 23(5):670-7. Epub 2020 Jan 16. DOI: https://doi.org/10.1089/jpm.2019.0515

• Surgery and surgical consult rates for early stage lung cancer in Ontario: a population-based study

  Bendzsak AM, Waddell TK, Urbach DR, Darling GE. Ann Thorac Surg. 2017; 103(3):906-10. Epub 2016 Dec 7.

• Symptom assessment following surgery for lung cancer: a Canadian population-based retrospective cohort study

  Hirpara DH, Coburn N, Darling G, Kidane B, Rousseau M, Gupta V, Doherty M, Zuk V, Delibasic V, Chan W, Hallet J. Ann Surg. 2021 Feb 10 [Epub ahead of print]. DOI: https://doi.org/10.1097/SLA.0000000000004802

• Performance and cost-effectiveness of computed tomography lung cancer screening scenarios in a population-based setting: a microsimulation modeling analysis in Ontario, Canada

  ten Haaf K, Tammemagi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF. PLoS Med. 2017; 14(2):e1002225.

• An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data

  Bremner KE, Krahn MD, Warren JL, Hoch JS, Barrett MJ, Liu N, Barbera L, Yabroff KR. Palliat Med. 2015; 29(10):918-28. Epub 2015 Sep 1.

• Characterizing regional variability in lung cancer outcomes across Ontario—a population-based analysis

  Mullin ML, Shellenberger J, Whitehead M, Brundage M, Eisenhauer EA, Lougheed MD, Parker CM, Digby GC. Curr Oncol. 2022, 29(12):9640-59. Epub 2022 Dec 7. DOI: https://doi.org/10.3390/curroncol29120757

• Home care utilization and costs in stage IV lung cancer: a Canadian public payer experience

  Mittmann N, Seung SJ, Liu N, Porter J, Leighl N, Trudeau M, Evans WK, Earle C. Lung Cancer Manag. 2014; 3(6):439-42.

• Survival effects of time to surgery for Stage I lung cancer: a population-based study

  Finley C, Begum H, Akhtar-Danesh G, Akhtar-Danesh N. Surg Oncol. 2022; Mar 25 [Epub ahead of pring]. DOI: https://doi.org/10.1016/j.suronc.2022.101744

• Province-wide analysis of patient-reported outcomes for stage IV non-small cell lung cancer

  Tjong MC, Doherty M, Tan H, Chan WC, Zhao H, Hallet J, Darling G, Kidane B, Wright FC, Mahar A, Davis LE, Delibasic V, Parmar A, Mittmann N, Coburn N, Louie AV. Oncologist. 2021; 26(10):e1800-11. Epub 2021 Jul 3. DOI: https://doi.org/10.1002/onco.13890

• Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada

  Cuffe S, Booth CM, Peng Y, Darling GE, Li G, Kong W, Mackillop WJ, Shepherd FA. J Clin Oncol. 2012; 30(15):1813-21. Epub 2012 Apr 23.

• End-of-life care for lung cancer patients in the United States and Ontario

  Warren JL, Barbera L, Bremner KE, Yabroff KR, Hoch JS, Barrett MJ, Luo J, Krahn MD. J Natl Cancer Inst. 2011; 103(11):853-62. Epub 2011 May 18.

• Quality of end-of-life care for people with advanced non-small cell lung cancer in Ontario: a population-based study

  Goldie CL, Nguyen P, Robinson AG, Goldie CE, Kircher CE, Hanna TP. Curr Oncol. 2021; 28(5):3297-315. Epub 2021 Aug 26. DOI: https://doi.org/10.3390/curroncol28050286

• Adoption of adjuvant chemotherapy for non–small-cell lung cancer: a population-based outcomes study

  Booth CM, Shepherd FA, Peng Y, Darling GE, Li G, Kong W, Mackillop WJ. J Clin Oncol. 2010; 28(21):3472-8. Epub 2010 Jun 21.

• Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in Canada

  Perdrizet K, Sutradhar R, Li Q, Liu N, Earle CC, Leigh NB. J Thorac Dis. 2021;13(9):5419-29. Epub 2021 Sep 1. DOI: https://dx.doi.org/10.21037/jtd-21-804

• End-of-life care in individuals with respiratory diseases: a population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer

  Kendzerska T, Nickerson JW, Hsu AT, Gershon AS, Talarico R, Mulpuru S, Pakhale S, Tanuseputro P. Int J Chron Obstruct Pulmon Dis. 2019; 14:1691-701. Epub 2019 Jul 31. DOI: 10.2147/COPD.S210916.

• Long-term functional outcomes among older adults undergoing video-assisted versus open surgery for lung cancer: a population-based cohort study

  Hallet J, Rousseau M, Gupta V, Hirpara D, Zhao H, Coburn N, Darling G, Kidane B; members of the REcovery after Surgical Therapy for Older adults Research – Cancer (RESTORE-Cancer) group. Ann Surg. 2022; Jan 21 [Epub ahead of print]. DOI: https://doi.org/10.1097/SLA.0000000000005387

• March 2011

  • Heart attack patients with depression less likely to receive priority care in emergency rooms
  • Long-term use of osteoporosis drugs linked to rare fractures of the thigh bone
  • Painkiller prescribing rates and outcomes vary among Ontario family physicians
  • Study finds significant variation in rates of lung cancer incidence and surgical care in Ontario
  • Majority of colonoscopy-related adverse events detectable within 14 days of procedure

• June/July 2011

  • Lower risk of death in COPD patients taking long-acting beta-agonists
  • End-of-life care for lung cancer patients differs in Ontario and the United States
  • Less than half of patients with multiple sclerosis continually adhere to drug therapies
  • Improving system efficiency by implementing stroke best practices
  • Myocardial perfusion imaging predicts cardiovascular outcomes

• Februrary 2005

  • Blueprint for children’s health services needed in Ontario
  • SSRIs do not increase risk of digoxin toxicity
  • Minorities under represented in clinical trials
  • Surgeon specialty and volume impacts outcomes in patients undergoing surgery for lung cancer
  • Single data source could help improve heart attack care in Canada

• May 2008

  • Rise in prevalence of hypertension partly explained by decline in mortality
  • Children of immigrants more likely to be immunized than children of non-immigrants
  • Study finds risk of serious assault spikes with alcohol sales
  • Some ACE inhibitors less beneficial in treating elderly patients with congestive heart failure
  • Study describes indicators of aggressive end-of-life care among lung cancer patients

• Long-term dependency in older adults after surgery or stereotactic body radiation therapy for stage I non-small cell lung cancer

  Hirpara DH, Kidane B, Louie AV, Zuk V, Darling G, Rousseau M, Chesney T, Coburn N, Hallet J; REcovery after Surgical Therapy for Older adults REsearch – Cancer (RESTORE-C) group. Ann Surg. 2022; Aug 15 [Epub ahead of print]. DOI: https://doi.org/10.1097/SLA.0000000000005660

• Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study

  Weichenthal S, Bai L, Hatzopoulou M, Van Ryswyk K, Kwong JC, Jerrett M, van Donkelaar A, Martin RV, Burnett RT, Lu H, Chen H. Environ Health. 2017; 16(1):64.

• A population-based analysis of outcomes after radiotherapy in intensive care unit patients with lung cancer

  Louie AV, Li L, Bray Jenkyn K, Allen B, Rodrigues GB, Warner A, Palma DA, Shariff SZ. J Thorac Dis. 2018; 10(3):1440-8.

• Quantifying comorbidity in individuals with chronic obstructive pulmonary disease: a population study

  Gershon AS, Mecredy GC, Guan J, Victor JC, Goldstein R, To T. Eur Respir J. 2015; 45(1):51-9. Epub 2014 Aug 20.

• Mortality trends in women and men with COPD in Ontario, Canada, 1996–2012

  Gershon A, Hwee J, Victor JC, WIlton A, Wu R, Day A, To T. Thorax. 2015; 70(2):121-6. Epub 2014 Nov 26.

• A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer

  Mahar AL, Coburn NG, Johnson AP. Lung Cancer. 2014; 86(2):281-7. Epub 2014 Sep 20.

• The Smoking Regulatory Index: a new way to measure public health performance

  Rosenfield D, Manuel DG, Alter DA. CMAJ. 2006; 174(10):1403-4.

• Cancer prevalence, incidence and mortality in people who experience incarceration in Ontario, Canada: a population-based retrospective cohort study

  Kouyoumdjian FG, Pivnick L, McIsaac KE, Wilton AS, Lofters A, Hwang SW. PLoS One. 2017; 12(2):e0171131.

• Change in treatment modality and trends in survival among stage I non-small cell lung cancer patients: a population-based study

  Akhtar-Danesh GG, Finley C, Seow HY, Shakeel S, Akhtar-Danesh N. J Thorac Dis. 2020; 12(9):4670-9. Epub 2020 Aug 1. DOI: https://doi.org/10.21037/jtd-20-1387

• Assessing the association of targeted therapy and intracranial metastatic disease

  Erickson AW, Habbous S, Wright F, Lofters AK, Jerzak KJ, Das S. JAMA Oncol. 2021; 7(8):1220-4. Epub 2021 Jun 3. DOI: https://doi.org/10.1001/jamaoncol.2021.1600

• «
• 1
• 2
• »